Comparison of Ticagrelor And Clopidogrel on Inflammatory Biomarkers And Vascular Endothelial Function
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 350 participants.
Also called NCT02123004
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 350 participants
- Sponsor
- Registry
-
NCT02123004
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT02123004. Randomized; no masking; primary purpose treatment. Start 2014-04 (registry gives no type); primary completion 2016-05 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of Ticagrelor And Clopidogrel on Inflammatory Biomarkers And Vascular Endothelial Function
- Acronym
- TIGERCAVE
- Condition
- ST-Segment Elevation Myocardial Infarction
- Intervention (Drug)
- Ticagrelor
- Intervention (Drug)
- Clopidogrel
- Lead sponsor
- Jinan Central Hospital
Record details
- Record id
cardio:ct-nct02123004- Content hash
54be69522fe8748daf5496e335948b31c3947c2698ea132ba7bac8eeecd92d16